Journal of Assisted Reproduction and Genetics

, Volume 21, Issue 1, pp 19–25 | Cite as

Regulating Preimplantation Genetic Diagnosis—How to Control PGD

  • Naoki TakeshitaEmail author
  • Harumi Kubo


Purpose: To assess the regulations for Preimplantation Genetic Diagnosis (PGD). How to regulate and control PGD. Is any special licensing procedure necessary?

Methods: A review of the statements of the organization and the Japan Society of Obstetrics and Gynecology (JSOG). Also, we assess the JSOG guidelines for PGD and the statements on diagnosis of genetic diseases of the Japan Society of Human Genetics. We discuss extra licenses and qualifications for laboratories, staff, and directors.

Results: At present, there are no regulations governing PGD for laboratories, scientists, directors, and staff. Regulations are set by committees and organizations of the countries involved. We don't have any worldwide system of controls. In Japan, we are considering regulations in the fields of reproduction and genetics.

Conclusions: PGD requires high-level techniques in taking samples, and high-level knowledge about genetic diseases. In diagnosis, we have to be as close to 100% accurate as possible. However, samples for PGD are so small that there is always a risk of failure. Also, we are required to have highly specialized knowledge about reproduction and genetics. In Japan, JSOG has a plan to join with the Society for Investigating Infertility and Society for Genetics.

Embryo biopsy polymerase chain reaction (PCR) preimplantation genetic diagnosis (PGD) preimplantation genetic diagnosis-aneuploidy screening (PGD-AS) 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Handyside A, Kontogianni E, Hardy K, Wimston R: Pregnancies from biopsied human preimplantation embryos sexed by Y-specific DNA amplification. Nature 1990;344:768-770.Google Scholar
  2. 2.
    Munne S, Lee A, Rosenwaks Z, Grifo J, Cohen J: Diagnosis of major chromosome aneuploidies in human preimplantation embryos. Hum Reprod 1993;8:2185-2191.Google Scholar
  3. 3.
    ESFRE PGD Consortium Steering Committee. ESHRE Preimplantation Genetic Diagnosis Consortium: Data collection III (May 2001). Hum Reprod 2002;17:233-246.Google Scholar
  4. 4.
    Griffin DK, Wilton LJ, Handyside AH, Atkinson G, Winston RML, Delhanty JDA: Diagnosis sexi in preimplantation embryos by fluorescence in situ hybridization. BMJ 1993.Google Scholar
  5. 5.
    Staessen C, Van Assche E, Joris H, Bonduelle M, Vandervorst M, Liebaers I, Van Steirteghem A: Clinical experience of sex determination by fluorescent in situ hybridization for preimplantation genetic diagnosis. Mol Hum Reprod 1999;5:382-389.Google Scholar
  6. 6.
    Verlinsky Y, Eviskov S: Karyotyping of human oocytes by chromosomal analysis of the second polar body. Mol Hum Reprod 1999;5:89-96.Google Scholar
  7. 7.
    Statement of Japan Society of Obstetrics and Gynecology: Acta Obstet Gynaecol Jpn 1999;51:15-43.Google Scholar
  8. 8.
    Guideline of Japan Society of Human Genetics for diagnosis of genetic disease, 1996.Google Scholar
  9. 9.
    Guideline of Japan Society of Human Genetics for program for education for a specialist for genetics, 1998.Google Scholar
  10. 10.
    Guideline of Japan Society of Obstetrics and Gynecology for reiteration, 1981.Google Scholar
  11. 11.
    Guideline of Japan Society of Obstetrics and Gynecology—The number of institutions which have performed or registered IVF-ET-, 2000.Google Scholar
  12. 12.
    Statement of Japan Society for Fertility and Sterility. 1996; Guideline of Japan Society of Fertility and Sterility.Google Scholar
  13. 13.
    The First Meeting of Reproduction and Genetic Counseling. 2001, Tokyo.Google Scholar

Copyright information

© Plenum Publishing Corporation 2004

Authors and Affiliations

  1. 1.The 1st Department of Obstetrics and GynecologyTOHO University School of MedicineOhta-Ku, Tokyo 143-8541

Personalised recommendations